BioLASCO Taiwan Co., Ltd.

6662

TW0006662000

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 03:30:00 15/07/2024 am IST			5-day change	1st Jan Change
40 ^TWD	+1.52%		+1.91%	+20.48%

09/07	BioLASCO Taiwan Co., Ltd. Announces Cash Dividend, Payable on August 28, 2024	CI
14/05	BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

BioLASCO Taiwan Co., Ltd. Announces Cash Dividend, Payable on August 28, 2024

July 09, 2024 at 03:34 pm IST

BioLASCO Taiwan Co., Ltd. announced cash dividends TWD 42,260,460,TWD 1.65 per share. Ex-rights (Ex-dividend) date: July 25, 2024. Ex-rights (Ex-dividend) record date: July 31, 2024.

Payment date of cash dividend distribution: August 28, 2024.

Latest news about BioLASCO Taiwan Co., Ltd.

BioLASCO Taiwan Co., Ltd. Announces Cash Dividend, Payable on August 28, 2024	09/07	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/23/08	CI
BioLASCO Taiwan Co., Ltd. Announces Cash Dividend	31/23/31	CI
BioLASCO Taiwan Co., Ltd. Announces Change of Remuneration Committee	12/23/12	CI
BioLASCO Taiwan Co., Ltd. Announces Change of Audit Committee	12/23/12	CI
BioLASCO Taiwan Co., Ltd. Announces Board Changes	12/23/12	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	04/22/04	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	05/22/05	CI
BioLASCO Taiwan Co., Ltd. Announces Cash Dividend, Payable on August 26, 2022	05/22/05	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	05/22/05	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	06/21/06	CI
BioLASCO Taiwan Co., Ltd. Announces CEO Changes	05/21/05	CI
Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	06/21/06	CI
BioLASCO Taiwan Co., Ltd. Announces Cash Dividend, Payable on September 22, 2021	05/21/05	CI
BioLASCO Taiwan Co., Ltd. Elects Liu, Wei-Ming as Natural-Person Director	05/21/05	CI
Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	26/21/26	CI
BioLASCO Taiwan Co., Ltd. Appoints Stacey Yu as Corporate Governance Officer	25/21/25	CI
BioLASCO Taiwan Co., Ltd. Renews Ten-Year Distribution and Propagation Agreement with Charles River Laboratories International, Inc	18/21/18	CI
BioLASCO Taiwan Co., Ltd. Announces Resignation of Chen,Chien-Chang as Director	03/21/03	CI

Chart BioLASCO Taiwan Co., Ltd.

Duration

Period

More charts

BioLASCO Taiwan Co., Ltd. is a Taiwan-based company mainly engaged in the production of Specific Pathogen Free (SPF) laboratory animals and the high-value special-mode experimental animals, as well as the introduction and production of highly-applicable disease-mode animals. The company also provides equipment related to feeding, supplies and testing platform, life science research and pharmaceutical development services.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BIOLASCO TAIWAN CO., LTD.	+20.48%	3.1Cr
MODERNA, INC.	+22.15%	4.65TCr
LONZA GROUP AG	+45.94%	4.18TCr
IQVIA HOLDINGS INC.	-2.37%	4.08TCr
ALNYLAM PHARMACEUTICALS, INC.	+33.84%	3.3TCr
CELLTRION, INC.	-6.35%	2.83TCr
ICON PUBLIC LIMITED COMPANY	+20.42%	2.78TCr
UNITED THERAPEUTICS CORPORATION	+48.83%	1.43TCr
MEDPACE HOLDINGS, INC.	+45.00%	1.37TCr
BIO-TECHNE CORPORATION	+0.06%	1.22TCr